用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
IRX THERAPEUTICS INC [US](5)
HADDEN JOHN W [US](2)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'IRX THERAPEUTICS INC [US]'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
尾页
共
5
条记录, 当前第1/1页。
公开号
公开日
申请号
申请日
1.
EP2420249A1
2012/2/22
EP20110183836
2004/8/5
专利标题
:Vaccine immunotherapy for immune suppressed patients
专利权人
:
IRX THERAPEUTICS INC [US]
;
Use of a natural cytokine mixture (NCM) including the cytokines IL-1, IL-2, IL-6, IL-8, IL-12, IFN-gamma, TNF-alpha, GM-CSF and G-CSF, for immunotherapy of a cancer patient in a dosage regime comprising (i) administration of the NCM in an inactive amount, and (ii) administration of Indomethacin and cyclophosphamide.
2.
MX2009008690A
2009/9/4
MX20090008690
2009/8/13
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS.
专利权人
:
IRX THERAPEUTICS INC [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
3.
WO2008101154A2
2008/8/21
WO2008US54070
2008/2/15
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
HADDEN JOHN W [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
4.
CA2715529A1
2008/8/21
CA20082715529
2008/2/15
专利标题
:IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab- CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the ...
5.
WO2005025494A2
2005/3/24
WO2004US25518
2004/8/5
专利标题
:VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
专利权人
:
IRX THERAPEUTICS INC [US]
;
HADDEN JOHN W [US]
;
A method of immunotherapy to treat cancer or a synergistic anti-cancer treatment by administering an effective amount of a natural cytokine mixture (NCM), an effective amount of cyclophosphamide (CY), or an effective amount of indomethacin (INDO), wherein the NCM, CY, or INDO are administered singly or in communications thereof. An anti-metastatic treatment method by promoting differentiation and maturation of immature dendritic cells in a lymph node
首页
1
尾页
共
5
条记录, 当前第1/1页。
当前查询条件: [专利权人] 包含 'IRX THERAPEUTICS INC [US]'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文